Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021)
Scholar Rock Holding's (SRRK) quarterly Other Non-Current Liabilities came in at $3000.0 in Q2 2021, down 25.0% quarter-over-quarter from $4000.0 in Q1 2021.
Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021) Analysis & Trends
Scholar Rock Holding's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3000.0 for Q2 2021.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $3000.0 in Q2 2021; TTM through Jun 2021 was $3000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $5000.0, down 44.44% from the prior year.
- Other Non-Current Liabilities retreated to $3000.0 in Q2 2021 per SRRK's latest filing, from $4000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $37000.0 in Q4 2017 and bottomed at $3000.0 in Q2 2021.
- The 4-year median for Other Non-Current Liabilities is $5000.0 (2020), against an average of $11600.0.
- Biggest YoY gain for Other Non-Current Liabilities was 44.44% in 2020; the steepest drop was 44.44% in 2020.
- Year by year, Other Non-Current Liabilities stood at $37000.0 in 2017, then slumped by 75.68% to $9000.0 in 2019, then plunged by 44.44% to $5000.0 in 2020, then plunged by 40.0% to $3000.0 in 2021.
- Per Business Quant, the three latest SRRK Other Non-Current Liabilities figures stand at $3000.0 (Q2 2021), $4000.0 (Q1 2021), and $5000.0 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2017 | 37,000.00 |